Home Tags COVID-19 vaccine
Tag: COVID-19 vaccine
Moderna anticipates that it may have sufficient data to seek a regulatory OK in November
Never before have we reached herd immunity via natural infection with a novel virus, and COVID-19 is a novel virus.
The development of safe and effective vaccines to prevent SARS-CoV-2 infection and/or COVID-19 is essential to help bring the pandemic under control.
The administration proposed labeling a Covid-19 vaccine authorization a ‘pre-licensure,’ which FDA says would undermine its procedures.
Because of the rapid global spread of SARS-CoV-2 infection and the high mortality rate, development of a vaccine is an urgent task.
None of the candidate vaccines in advanced clinical trials so far has demonstrated a “clear signal” of efficacy at the level of at least 50% sought by the WHO
Yea, get your scientific information from the news media!
The Trump administration said it will not join a global effort to develop, manufacture and equitably distribute a coronavirus vaccine, in part because the World Health Organization is involved.
Re-infection has raised fears about the efficacy of potential vaccines against the virus
Tracking 200 experimental vaccines to combat COVID-19
Russia Claims They are Being Negatively Targeted for Their COVID-19 Vaccine. https://twitter.com/Newsweek/status/1296478624275738624?s=20 Health Editor's Note: The idea that there is an "information war" against the Russian...
Experts have voiced unease over Moscow's rapid approval process for the vaccine.
OWS aims to deliver up to 300 million doses of a safe and effective vaccine for COVID-19 in early 2021, as part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics (collectively known as countermeasures).
Trial of 30,000 individuals
According to the World Health Organization’s latest table of COVID-19 vaccines, 124 candidates are at various stages of development with eight different technologies, or platforms.
More than $1bn US BARDA investment to support development and production of the vaccine
The vaccine was developed at the University of Oxford Jenner Institute.
The authors emphasize that developing COVID-19 vaccines will require unprecedented cooperation from governments, academic institutions, industry, and global philanthropic partners